Perioperative N-acetylcysteine: evidence and indications

Area of Science:

• Anesthesiology and Perioperative Medicine
• Pharmacology
• Critical Care Medicine

Background:

• Nonopioid analgesics are crucial for managing perioperative pain and minimizing opioid-related risks.
• N-acetylcysteine (NAC), known for treating acetaminophen toxicity, is being explored for its potential perioperative analgesic properties.
• NAC influences key biological pathways, including glutathione synthesis, oxidant scavenging, glutamate receptor modulation, and neuroinflammation.

Purpose of the Study:

• To evaluate the potential of N-acetylcysteine (NAC) as a perioperative analgesic.
• To explore NAC's impact on reducing postoperative opioid consumption.
• To review the safety profile and potential adverse effects of NAC in the perioperative setting.

Main Methods:

• Review of existing literature on N-acetylcysteine (NAC) in perioperative care.
• Analysis of studies investigating NAC's analgesic effects and opioid-sparing potential.
• Assessment of reported side effects and safety data associated with NAC administration.

Main Results:

• NAC may offer analgesic benefits and reduce the need for postoperative opioids in certain perioperative settings.
• Potential benefits extend to arrhythmia prevention, reduced contrast-induced nephropathy, improved liver function, and better pulmonary outcomes.
• NAC is generally well-tolerated, but parenteral administration carries risks of anaphylactoid reactions, including bronchospasm.

Conclusions:

• N-acetylcysteine (NAC) shows promise as an adjunct for perioperative analgesia and opioid reduction.
• Further large-scale randomized trials are necessary to definitively establish NAC's efficacy and optimal use in perioperative pain management.
• Understanding NAC's safety profile, including potential gastrointestinal and anaphylactoid reactions, is critical for its clinical application.